Community Concerns Regarding the Google-Autism Speaks Ten Thousand Genomes Program (AUT10K)
By admin,
ASAN
| 06. 12. 2014
In response to the recent announcement of the new Google-Autism Speaks collaboration to produce, expand and analyze the world’s largest private collection of DNA samples of autistic children and adults, many in the autistic community have expressed significant concerns regarding the initiative. The program, entitled the Autism Speaks Ten Thousand Genomes Program (AUT10K), will utilize genetic material collected from autistic children and adults as part of the Autism Genetic Resource Exchange (AGRE) for academic and commercial research purposes. A number of critical questions and concerns have emerged regarding the program:
- Autism Speaks Lacks Representation from the Community it Purports to Serve: Autism Speaks is a particularly concerning partner for such an initiative. The organization has long been subject to criticism for its lack of any representation of autistic people on its board of directors or in its senior leadership. Autism Speaks’ research budget has largely ignored research inquiries focused on improving the lives of autistic people alive today, with only 1% of its research budget going towards services issues and 0.25% going towards research on the needs of adults. Furthermore...
Related Articles
By Calder Mchugh, Politico | 05.15.2026
There will come a time, in the not-so-distant future, when you decide to stick a computer chip in your brain.
At least, that’s what D. Scott Phoenix told the audience at TED 2026 in Vancouver last month.
“Someone you work...
By Nanette Elster, Kayhan Parsi, and Art Caplan, The American Journal of Bioethics | 05.06.2026
“Better babies.” “Fitter families.” “Survival of the fittest.” “Three generations of imbeciles are enough.” These phrases are not merely historical reminders of the United States’ regrettable eugenic past but are appearing in an increasingly eugenic present. Eugenics may have seemed...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 05.06.2026
Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.
"These are saliva samples as well as blood," says Schleede, a geneticist who runs Herasight Inc.'s lab in Morrisville, N.C. "We also...
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...